Szeto Cheuk-Chun, Wong Teresa Yuk-Hwa, Chow Kai-Ming, Leung Chi-Bon, Li Philip Kam-Tao
Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China People's Republic of China.
Am J Kidney Dis. 2003 Sep;42(3):567-74. doi: 10.1016/s0272-6386(03)00790-x.
Culture-negative peritonitis is a serious complication in peritoneal dialysis patients.
We studied all consecutive episodes of culture-negative peritonitis in our unit from 1995 to 2001. We identified 1,182 episodes of peritonitis recorded; 212 episodes in 149 patients had negative culture results.
The overall primary response rate was 67.5%, and the complete cure rate was 37.7%. In 95 episodes (44.8%), technical problems during the collection of dialysis effluent were suspected. There was a history of antibiotic therapy within 30 days before the onset in 56 episodes (26.4%). Recent antibiotic therapy was associated with a lower primary response rate (31 of 56 versus 113 of 156 episodes; P = 0.019) and lower complete cure rate (12 of 56 versus 68 of 156 episodes; P = 0.003). Furthermore, a history of peritonitis from 31 to 120 days before the onset also was associated with a lower complete cure rate (P = 0.001). Multivariate analysis showed that recent peritonitis was the only independent predictor of treatment failure (odds ratio, 2.87; 95% confidence interval, 1.56 to 5.29).
Most of the culture-negative peritonitis could be explained by recent antibiotic therapy or technical problems during dialysate culture. Recent peritonitis and antibiotic therapy are associated with a poor treatment response. Early Tenckhoff catheter removal is recommended in this group of patients.
培养阴性腹膜炎是腹膜透析患者的一种严重并发症。
我们研究了1995年至2001年在我们科室发生的所有连续性培养阴性腹膜炎病例。我们确定共记录了1182例腹膜炎病例;149例患者中的212例培养结果为阴性。
总体初始反应率为67.5%,完全治愈率为37.7%。在95例(44.8%)病例中,怀疑在收集透析液期间存在技术问题。56例(26.4%)病例在发病前30天内有抗生素治疗史。近期抗生素治疗与较低的初始反应率(56例中的31例对比156例中的113例;P = 0.019)和较低的完全治愈率(56例中的12例对比156例中的68例;P = 0.003)相关。此外,发病前31至120天有腹膜炎病史也与较低的完全治愈率相关(P = 0.001)。多因素分析显示近期腹膜炎是治疗失败的唯一独立预测因素(比值比,2.87;95%置信区间,1.56至5.29)。
大多数培养阴性腹膜炎可由近期抗生素治疗或透析液培养期间的技术问题解释。近期腹膜炎和抗生素治疗与较差的治疗反应相关。建议对该组患者早期拔除Tenckhoff导管。